Hoevelmann, Julian
Mahfoud, Felix
Lauder, Lucas
Scheller, Bruno
Böhm, Michael
Ewen, Sebastian
Article History
Accepted: 7 December 2020
First Online: 4 January 2021
Compliance with ethical guidelines
:
: F. Mahfoud is supported by the Deutsche Gesellschaft für Kardiologie (DGK) and Deutsche Forschungsgemeinschaft (SFB TRR219) and has received scientific support and speaker honoraria from Bayer, Boehringer Ingelheim, Medtronic, and ReCor Medical. M. Böhm is supported by the Deutsche Forschungsgemeinschaft (SFB TRR218). S. Ewen received speakers or consultant honorarium and/or travel support from Medtronic, Recor, Bayer, Daiichi Sankyo, Boehringer Ingelheim, Novartis, AstraZeneca, Akcea Therapeutics, and Bristol-Myers Squibb-Pfizer. J. Hoevelmann, L. Lauder and B. Scheller declare that they have no competing interests.
: For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case.